Advanced search
Publication Cover
Biologics: Targets and Therapy Volume 2, 2008 - Issue 3
Submit an article Journal homepage
96
Views
5
CrossRef citations to date
0
Altmetric
Review

Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias

Aldo M Roccaro1 Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USACorrespondence[email protected]
,
Irene M Ghobrial1 Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
,
Simona Blotta1 Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
,
Steven P Treon1 Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
,
Michele Malagola2 Unit of Blood Diseases and Cell Therapies, University of Brescia Medical School, Brescia, Italy
,
Kenneth C Anderson1 Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
,
Paul G Richardson1 Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
&
Domenico Russo2 Unit of Blood Diseases and Cell Therapies, University of Brescia Medical School, Brescia, Italy
 show all
Pages 419-431 | Published online: 12 Sep 2008

Reprints and Permissions

Taylor & Francis does not sell reprints or permissions for this article. Please refer to the 'Licensing' tab on the article menu bar for information on the reuse conditions associated with this license type.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.